Povidone iodine treatment is deleterious to human ocular surface conjunctival cells in culture

William Swift, Jeffrey A Bair, Wanxue Chen, Michael Li, Sole Lie, Dayu Li, Menglu Yang, Marie A Shatos, Robin R Hodges, Miriam Kolko, Tor P Utheim, Wendell Scott, Darlene A Dartt, William Swift, Jeffrey A Bair, Wanxue Chen, Michael Li, Sole Lie, Dayu Li, Menglu Yang, Marie A Shatos, Robin R Hodges, Miriam Kolko, Tor P Utheim, Wendell Scott, Darlene A Dartt

Abstract

Objective: To determine the effect of povidone iodine (PI), an antiseptic commonly used prior to ocular surgery, on viability of mixed populations of conjunctival stratified squamous and goblet cells, purified conjunctival goblet cells and purified conjunctival stromal fibroblasts in primary culture.

Methods and analysis: Mixed population of epithelial cells (stratified squamous and goblet cells), goblet cells and fibroblasts were grown in culture from pieces of human conjunctiva using either supplemented DMEM/F12 or RPMI. Cell type was evaluated by immunofluorescence microscopy. Cells were treated for 5 min with phosphate-buffered saline (PBS); 0.25%, 2.5%, 5% or 10% PI in PBS; or a positive control of 30% H2O2. Cell viability was determined using Alamar Blue fluorescence and a live/dead kit using calcein/AM and ethidium homodimer-1 (EH-1).

Results: Mixed populations of epithelial cells, goblet cells and fibroblasts were characterised by immunofluorescence microscopy. As determined with Alamar Blue fluorescence, all concentrations of PI significantly decreased the number of cells from all three preparation types compared with PBS. As determined by calcein/EH-1 viability test, mixed populations of cells and fibroblasts were less sensitive to PI treatment than goblet cells. All concentrations of PI, except for 0.25% used with goblet cells, substantially increased the number of dead cells for all cell populations. The H2O2 control also significantly decreased the number and viability of all three types of cells in both tests.

Conclusion: We conclude that PI, which is commonly used prior to ocular surgeries, is detrimental to human conjunctival stratified squamous cells, goblet cells and fibroblasts in culture.

Keywords: conjunctiva; ocular surface.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Identification of cell types in cultured conjunctiva. Mixed populations of cells containing populations of stratified squamous cells (A) and goblet cells (B) were grown on coverslips, fixed and labelled against unique markers for each cell type and used to determine the fractional cell population in mixed preparations. Stratified squamous cells were identified from mixed populations using antibodies against cytokeratin 4 (red), Bandeiraea Simplicifolia lectin (green) and DAPI (blue). Goblet cells were identified from mixed populations of cells (B) or purified goblet cell cultures (C) using antibodies against cytokeratin 7 (red), and Ulex Europeaus Agglutin 1 (green). Fibroblasts (D) were identified in purified cultures using antibodies against vimentin (red), and DAPI (blue). Representative stratified squamous and goblet cells are indicated with arrows in A and B. Cells were analysed from three individuals in A and B and four individuals in C and D. Cell types were counted and percentage of cell type is shown in E. Data are expressed as mean±SEM. DAPI, 4′,6-diamino-2-phenylindole.
Figure 2
Figure 2
Viability of cells after treatment with PI. Cultured mixed cells (A), purified goblet cells (B) and purified fibroblasts (C) were treated with PBS, 0.25%–10% PI or 30% H2O2 for 5 min. Relative fluorescence intensity of Alamar Blue is expressed as fold change when intensity of PBS was set to 1. Data are mean±SEM from three individuals. Asterisk (*) indicates significance from PBS. PBS, phosphate-buffered saline; PI, povidone iodine.
Figure 3
Figure 3
Viability of cultured mixed epithelial cells after treatment with PI. Cultured mixed epithelial cells were treated with PBS, 0.25%–10% PI or 30% H2O2 for 5 min. Calcein staining (green) indicates live cells, and EH-1 (red) indicates dead cells (A). The total number of cells counted for each group was recorded and analysed (B), and the percentage of dead cells as a per cent of total cells is indicated on the y-axis (C). Data are mean±SEM from three individuals. Asterisk (*) indicates significance from PBS. EH-1, ethidium homodimer-1; PBS, phosphate-buffered saline; PI, povidone iodine.
Figure 4
Figure 4
Viability of cultured goblet cells after treatment with PI. Cultured goblet cells were treated with PBS, 0.25%–10% PI or 30% H2O2 for 5 min. The total number of cells counted for each group was recorded and analysed (A), and the percentage of dead cells as a per cent of total cells is indicated on the y-axis (B). Data are mean±SEM from three individuals. Asterisk (*) indicates significance from PBS. PBS, phosphate-buffered saline; PI, povidone iodine.
Figure 5
Figure 5
Viability of cultured fibroblasts after treatment with PI. Cultured fibroblasts were treated with PBS, 0.25%–10% PI, or 30% H2O2 for 5 min. The total number of cells counted for each group was recorded and analysed (A), and the percentage of dead cells as a per cent of total cells is indicated on the y-axis (B). Data are mean±SEM from three individuals. Asterisk (*) indicates significance from PBS. PBS, phosphate-buffered saline; PI, povidone iodine.

References

    1. Dartt DA. Regulation of mucin and fluid secretion by conjunctival epithelial cells. Prog Retin Eye Res 2002;21:555–76. 10.1016/S1350-9462(02)00038-1
    1. Uchino Y, Woodward AM, Argüeso P. Differential effect of rebamipide on transmembrane mucin biosynthesis in stratified ocular surface epithelial cells. Exp Eye Res 2016;153:1–7. 10.1016/j.exer.2016.10.007
    1. Gipson I. Anatomy of the Conjunctiva, Cornea, and Limbus : Smolin G, Thoft R, The Cornea. Boston: Little, Brown, and Company, 1994: 3–24.
    1. Diebold Y, Ríos JD, Hodges RR, et al. . Presence of nerves and their receptors in mouse and human conjunctival goblet cells. Invest Ophthalmol Vis Sci 2001;42:2270–82.
    1. McGilligan VE, Gregory-Ksander MS, Li D, et al. . Staphylococcus aureus activates the NLRP3 inflammasome in human and rat conjunctival goblet cells. PLoS One 2013;8:e74010. 10.1371/journal.pone.0074010
    1. Ko BY, Xiao Y, Barbosa FL, et al. . Goblet cell loss abrogates ocular surface immune tolerance. JCI Insight 2018;3:1–3. 10.1172/jci.insight.98222
    1. Li D, Hodges RR, Bispo P, et al. . Neither non-toxigenic Staphylococcus aureus nor commensal S. epidermidi activates NLRP3 inflammasomes in human conjunctival goblet cells. BMJ Open Ophthalmol 2017;2:e000101. 10.1136/bmjophth-2017-000101
    1. Fujitsu Y, Fukuda K, Kimura K, et al. . Protection of human conjunctival fibroblasts from NO-induced apoptosis by interleukin-4 or interleukin-13. Invest Ophthalmol Vis Sci 2005;46:797–802. 10.1167/iovs.04-1016
    1. Graham JE, Moore JE, Jiru X, et al. . Ocular pathogen or commensal: a PCR-based study of surface bacterial flora in normal and dry eyes. Invest Ophthalmol Vis Sci 2007;48:5616–23. 10.1167/iovs.07-0588
    1. Cullor JS, Mannis MJ, Murphy CJ, et al. . In vitro antimicrobial activity of defensins against ocular pathogens. Arch Ophthalmol 1990;108:861–4. 10.1001/archopht.1990.01070080105044
    1. Seal DV, McGill JI, Mackie IA, et al. . Bacteriology and tear protein profiles of the dry eye. Br J Ophthalmol 1986;70:122–5. 10.1136/bjo.70.2.122
    1. Bouhenni R, Dunmire J, Rowe T, et al. . Proteomics in the study of bacterial keratitis. Proteomes 2015;3:496–511. 10.3390/proteomes3040496
    1. Speaker MG, Milch FA, Shah MK, et al. . Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 1991;98:639–50. discussion 50. 10.1016/S0161-6420(91)32239-5
    1. Bannerman TL, Rhoden DL, McAllister SK, et al. . The source of coagulase-negative staphylococci in the endophthalmitis vitrectomy study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch Ophthalmol 1997;115:357–61. 10.1001/archopht.1997.01100150359008
    1. Barroso LF, Cazella SP, Nepomuceno AB, et al. . Comparative efficacy of two different topical povidone-iodine 5% regimens in reducing conjunctival bacterial flora: A randomized parallel double-masked clinical trial. PLoS One 2017;12:e0189206. 10.1371/journal.pone.0189206
    1. Benson CE, Rogers KL, Suh DW. Dual application versus single application of povidone-iodine in reducing surgical site contamination during strabismus surgery. J Aapos 2014;18:347–50. 10.1016/j.jaapos.2014.02.014
    1. Friedman DA, Mason JO, Emond T, et al. . Povidone-Iodine contact time and lid speculum use during intravitreal injection. Retina 2013;33:975–81. 10.1097/IAE.0b013e3182877585
    1. Li B, Nentwich MM, Hoffmann LE, et al. . Comparison of the efficacy of povidone-iodine 1.0%, 5.0%, and 10.0% irrigation combined with topical levofloxacin 0.3% as preoperative prophylaxis in cataract surgery. J Cataract Refract Surg 2013;39:994–1001. 10.1016/j.jcrs.2013.02.039
    1. Nentwich MM, Rajab M, Ta CN, et al. . Application of 10% povidone iodine reduces conjunctival bacterial contamination rate in patients undergoing cataract surgery. Eur J Ophthalmol 2012;22:541–6. 10.5301/ejo.5000093
    1. Peden MC, Hammer ME, Suñer IJ. Dilute povidone-iodine prophylaxis maintains safety while improving patient comfort after intravitreal injections. Retina 2019;39:2219–24. 10.1097/IAE.0000000000002290
    1. Jiang J, Wu M, Shen T. The toxic effect of different concentrations of povidone iodine on the rabbit's cornea. Cutan Ocul Toxicol 2009;28:119–24. 10.1080/15569520903080511
    1. Shimada H, Arai S, Nakashizuka H, et al. . Reduction of anterior chamber contamination rate after cataract surgery by intraoperative surface irrigation with 0.25% povidone-iodine. Am J Ophthalmol 2011;151:11–17. 10.1016/j.ajo.2010.07.002
    1. Koerner JC, George MJ, Meyer DR, et al. . Povidone-Iodine concentration and dosing in cataract surgery. Surv Ophthalmol 2018;63:862–8. 10.1016/j.survophthal.2018.05.002
    1. García-Posadas L, Soriano-Romaní L, López-García A, et al. . An engineered human conjunctival-like tissue to study ocular surface inflammatory diseases. PLoS One 2017;12:e0171099. 10.1371/journal.pone.0171099
    1. Krenzer KL, Freddo TF. Cytokeratin expression in normal human bulbar conjunctiva obtained by impression cytology. Invest Ophthalmol Vis Sci 1997;38:142–52.
    1. Dartt DA, Hodges RR, Li D, et al. . Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. J Immunol 2011;186:4455–66. 10.4049/jimmunol.1000833
    1. García-Posadas L, Hodges RR, Li D, et al. . Interaction of IFN-γ with cholinergic agonists to modulate rat and human goblet cell function. Mucosal Immunol 2016;9:206–17. 10.1038/mi.2015.53
    1. Hayashi D, Li D, Hayashi C, et al. . Role of histamine and its receptor subtypes in stimulation of conjunctival goblet cell secretion. Invest Ophthalmol Vis Sci 2012;53:2993–3003. 10.1167/iovs.11-8748
    1. Hodges RR, Bair JA, Carozza RB, et al. . Signaling pathways used by EGF to stimulate conjunctival goblet cell secretion. Exp Eye Res 2012;103:99–113. 10.1016/j.exer.2012.08.010
    1. Hodges RR, Li D, Shatos MA, et al. . Lipoxin A4 activates ALX/FPR2 receptor to regulate conjunctival goblet cell secretion. Mucosal Immunol 2017;10:46–57. 10.1038/mi.2016.33
    1. Hodges RR, Li D, Shatos MA, et al. . Lipoxin A4 Counter-regulates Histamine-stimulated Glycoconjugate Secretion in Conjunctival Goblet Cells. Sci Rep 2016;6:36124. 10.1038/srep36124
    1. Li D, Hodges RR, Jiao J, et al. . Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretion. Mucosal Immunol 2013;6:1119–30. 10.1038/mi.2013.7
    1. Shatos MA, Ríos JD, Horikawa Y, et al. . Isolation and characterization of cultured human conjunctival goblet cells. Invest Ophthalmol Vis Sci 2003;44:2477–86. 10.1167/iovs.02-0550
    1. Shatos MA, Rios JD, Tepavcevic V, et al. . Isolation, characterization, and propagation of rat conjunctival goblet cells in vitro. Invest Ophthalmol Vis Sci 2001;42:1455–64.
    1. Fan F, Zhao Z, Zhao X, et al. . Reduction of Ocular Surface Damage and Bacterial Survival Using 0.05% Povidone-Iodine Ocular Surface Irrigation before Cataract Surgery. Ophthalmic Res 2019;62:166–72. 10.1159/000501373
    1. Saedon H, Nosek J, Phillips J, et al. . Ocular surface effects of repeated application of povidone iodine in patients receiving frequent intravitreal injections. Cutan Ocul Toxicol 2017;36:343–6. 10.1080/15569527.2017.1291665
    1. Ridder WH. 3rd, Oquindo C, Dhamdhere K, et al. Effect of Povidone Iodine 5% on the Cornea, Vision, and Subjective Comfort. Optom Vis Sci 2017;94:732–41.
    1. Kim S, Lee S, Chang H, et al. . In vivo fluorescence imaging of conjunctival goblet cells. Sci Rep 2019;9:15457. 10.1038/s41598-019-51893-4
    1. Gipson IK. Goblet cells of the conjunctiva: a review of recent findings. Prog Retin Eye Res 2016;54:49–63. 10.1016/j.preteyeres.2016.04.005
    1. Khan FA, Hussain MA, Khan Niazi SP, et al. . Efficacy of 2.5% and 1.25% Povidone-Iodine Solution for Prophylaxis of Ophthalmia Neonatorum. J Coll Physicians Surg Pak 2016;26:121–4.
    1. Özen Tunay Z, Ozdemir O, Petricli IS. Povidone iodine in the treatment of adenoviral conjunctivitis in infants. Cutan Ocul Toxicol 2015;34:12–15. 10.3109/15569527.2014.888077
    1. Carrim ZI, Mackie G, Gallacher G, et al. . The efficacy of 5% povidone-iodine for 3 minutes prior to cataract surgery. Eur J Ophthalmol 2009;19:560–4. 10.1177/112067210901900407
    1. Panahibazaz M, Moosavian M, Khataminia G, et al. . Sub-Conjunctival injection of antibiotics vs. povidone-iodine drop on bacterial colonies in phacoemulsification cataract surgery. Jundishapur J Microbiol 2014;7:e13108. 10.5812/jjm.13108
    1. Ferguson AW, Scott JA, McGavigan J, et al. . Comparison of 5% povidone-iodine solution against 1% povidone-iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study. Br J Ophthalmol 2003;87:163–7. 10.1136/bjo.87.2.163
    1. Shibata Y, Tanaka Y, Tomita T, et al. . Evaluation of corneal damage caused by iodine preparations using human corneal epithelial cells. Jpn J Ophthalmol 2014;58:522–7. 10.1007/s10384-014-0348-y
    1. Shimada H, Arai S, Nakashizuka H, et al. . Reduced anterior chamber contamination by frequent surface irrigation with diluted iodine solutions during cataract surgery. Acta Ophthalmol 2017;95:e373–8. 10.1111/aos.13390
    1. Merani R, McPherson ZE, Luckie AP, et al. . Aqueous chlorhexidine for intravitreal injection antisepsis: a case series and review of the literature. Ophthalmology 2016;123:2588–94. 10.1016/j.ophtha.2016.08.022
    1. Hamill MB, Osato MS, Wilhelmus KR. Experimental evaluation of chlorhexidine gluconate for ocular antisepsis. Antimicrob Agents Chemother 1984;26:793–6. 10.1128/AAC.26.6.793
    1. Gili NJ, Noren T, Törnquist E, et al. . Preoperative preparation of eye with chlorhexidine solution significantly reduces bacterial load prior to 23-gauge vitrectomy in Swedish health care. BMC Ophthalmol 2018;18:167. 10.1186/s12886-018-0844-9

Source: PubMed

3
Se inscrever